Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tango Therapeutics, Inc.

NASDAQ: TNGX · Life Sciences · 8 alerts · CIK 1819133

Share price
$24.17Close, Nov 16
Market cap
$4.1B
Shares outstanding
169.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tango Therapeutics, Inc. filings on SEC EDGAR ↗

6:39 PM ET Form 4
Insider Selling

Tango Therapeutics President, R&D Adam Crystal Sells $125K of Stock

Adam Crystal, President, R&D, sold 5,000 shares of Tango Therapeutics, Inc. at $25.00 a share, worth $125K in total on Nov 11, 2026. Shares held after the trade: 115,743 (-4.1%).

Value
$125K
Shares
5,000
Price
$25.00
Role
President, R&D
Holding change
-4.1%
Trade date
Nov 11, 2026
7:35 PM ET Form 4
Insider Selling

Tango Therapeutics President, R&D Adam Crystal Sells $112K of Stock

Adam Crystal, President, R&D, sold 5,000 shares of Tango Therapeutics, Inc. at $22.26 to $22.99 a share (average $22.42) in 2 transactions, worth $112K in total on Nov 2, 2026. Shares held after the trade: 115,743 (-0.9%).

Value
$112K
Shares
5,000
Average price
$22.42
Role
President, R&D
Holding change
-0.9%
Trade date
Nov 2, 2026
7:32 PM ET Form 4
Insider Selling

Tango Therapeutics Principal Accounting Officer Jessica Newcomb Sells $158K of Stock

Jessica Newcomb, Principal Accounting Officer, sold 7,031 shares of Tango Therapeutics, Inc. at $22.28 to $22.98 a share (average $22.42) in 2 transactions, worth $158K in total on Nov 2, 2026. Shares held after the trade: 52,090 (-2.7%).

Value
$158K
Shares
7,031
Average price
$22.42
Role
Principal Accounting Officer
Holding change
-2.7%
Trade date
Nov 2, 2026
5:37 PM ET Form 4
Insider Selling

Tango Therapeutics President, R&D Adam Crystal Sells $661K of Stock

Adam Crystal, President, R&D, sold 27,000 shares of Tango Therapeutics, Inc. at $24.45 to $25.32 a share (average $24.47) in 2 transactions, worth $661K in total on Oct 1, 2026. Shares held after the trade: 115,743 (-0.5%).

Value
$661K
Shares
27,000
Average price
$24.47
Role
President, R&D
Holding change
-0.5%
Trade date
Oct 1, 2026
7:42 PM ET Form 4
Insider Selling

Tango Therapeutics Principal Accounting Officer Jessica Newcomb Sells $199K of Stock

Jessica Newcomb, Principal Accounting Officer, sold 8,200 shares of Tango Therapeutics, Inc. at $22.80 to $25.17 a share (average $24.22) in 3 transactions, worth $199K in total on Sep 22, 2026. Shares held after the trade: 59,121 (-3.9%).

Value
$199K
Shares
8,200
Average price
$24.22
Role
Principal Accounting Officer
Holding change
-3.9%
Trade date
Sep 22, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.